Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Protagonist Therapeutics, Inc (PTGX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/20/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 9.6% stake in Protagonist Therapeutics, Inc. |
| 01/03/2023 |
SC 13G
| CITADEL ADVISORS LLC reports a 5.5% stake in Protagonist Therapeutics, Inc. |
| 02/10/2022 |
SC 13G
| STATE STREET CORP reports a 5.4% stake in INITIAL FILING PROTAGONIST THERAPEUTICS INC |
| 09/21/2021 |
SC 13G
| Point72 Asset Management, L.P. reports a 9.1% stake in Protagonist Therapeutics, Inc. |
| 02/17/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/22/2020 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 6.4% stake in Protagonist Therapeutics, Inc. |
| 02/07/2020 |
SC 13G
| BlackRock Inc. reports a 5.7% stake in PROTAGONIST THERAPEUTICS, INC. |
| 12/16/2019 |
SC 13G
| RTW INVESTMENTS, LLC reports a 8% stake in Protagonist Therapeutics, Inc |
| 07/01/2019 |
SC 13G
| INTEGRATED CORE STRATEGIES LLC reports a |
| 06/17/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 6.4% stake in Protagonist Therapeutics, Inc. |
| 12/10/2018 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.3% stake in Protagonist Therapeutics, Inc. |
| 07/02/2018 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7% stake in Protagonist Therapeutics, Inc. |
| 05/24/2018 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 6.9% stake in Protagonist Therapeutics, Inc. |
| 02/13/2017 |
SC 13G
| Pharmstandard International S.A. reports a 5.9% stake in Protagonist Therapeutics, Inc. |
| 01/26/2017 |
SC 13G
| CANAAN X L.P. reports a 14.7% stake in Protagonist Therapeutics, Inc. |
| 10/11/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 09/12/2016 |
SC 13G
| Aisling Capital IV, LP reports a 5.1% stake in Protagonist Therapeutics, Inc. |
| 08/25/2016 |
SC 13G
| Protagonist Therapeutics, Inc reports a 6.8% stake in Protagonist Therapeutics, Inc. |
| 08/19/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 08/19/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|